Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd667bcd915ae53115c74e86f9484975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b18242ed803cee41b3203b948e2eda3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_11ea8e05b8eeec6eb206678bae875293 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8d078a33117c82e1f9bed9bed9e9f2b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-009 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2451 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M29-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-94 |
filingDate |
2006-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d02ef45b75a32ba3b17ddccfe87a0bdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4432b125c1f7f66c69321b35104fbe94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_286cd11bcf4b0efb6f4ed2c704100af9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93714f37d29e61abdb11f8ab46dc271c |
publicationDate |
2006-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006281968-A1 |
titleOfInvention |
System, including method and apparatus for percutaneous endovascular treatment of functional mitral valve insufficiency |
abstract |
Among the four heart valves, the mitral is the most frequently affected by disease resulting in defective valve opening (stenosis) or incomplete closure (insufficiency). Most often this is due to distortion of the valve apparatus secondary to rheumatic or degenerative disease. These lesions, called “organic” require open heart surgery. In patients with coronary disease or with dilated cardiomyopathy the mitral valve can be insufficient although structurally normal. These valves are “functionally” insufficient. Because of the poor condition of these patients where open heart surgery carries a significant operative risk, less invasive percutaneous alternatives are being explored today. The present novel invention represents a radical departure from other procedures because it repositions the posterior papillary muscle utilizing a device located in the interventricular veins. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701228-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012190918-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10925730-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11553924-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008249618-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8900295-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009012354-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11026791-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE47490-E http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4009911-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010070649-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201340-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11278293-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018264247-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10315023-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9414824-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723771-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008071365-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10245013-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10799356-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9364209-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008269876-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285003-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9585647-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111664-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9962144-B2 |
priorityDate |
2005-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |